Compass Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Commander Aggregator, LP and related entities report their beneficial ownership in Compass Therapeutics, Inc. has fallen to 4.5% due to an increase in the issuer's outstanding shares.
NASDAQ
OrbiMed Advisors and OrbiMed Capital GP V LLC reported a decrease in their beneficial ownership of Compass Therapeutics, Inc. common stock to 8.9% due to an increase in the number of outstanding shares.
NASDAQ
OrbiMed Advisors and affiliated entities have significantly reduced their beneficial ownership in Compass Therapeutics, Inc. by selling over 7 million shares, though they retain an 11.0% stake.